Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience

被引：15
作者：
Antoniou, C. [1 ]
Dessinioti, C. [1 ]
Stratigos, A. [1 ]
Avgerinou, G. [1 ]
Stavropoulos, P. [1 ]
Katsambas, A. [1 ]
机构：
[1] Univ Athens, A Sygros Hosp, Dept Dermatol, Athens, Greece
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2009年 / 23卷 / 08期
关键词：
ARTHRITIS; THERAPY;
D O I：
10.1111/j.1468-3083.2009.03093.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：979 / 982
页数：5
相关论文
共 10 条
[1]   Elevated triglyceride and cholesterol levels after intravenous antitumour necrosis factor-α therapy in a patient with psoriatic arthritis and psoriasis vulgaris [J].
Antoniou, C. ;
Dessinioti, C. ;
Katsambas, A. ;
Stratigos, A. J. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (05) :1090-1091
[2]   Psoriasis and psoriatic arthritis: separate or one and the same? [J].
Ciocon, D. H. ;
Kimball, A. B. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (05) :850-860
[3]   The effect of weight on the efficacy of biologic therapy in patients with psoriasis [J].
Clark, Lily ;
Lebwohl, Mark .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (03) :443-446
[4]   Initial experience with routine administration of etanercept in psoriasis [J].
de Groot, M. ;
Appelman, M. ;
Spuls, P. I. ;
de Rie, M. A. ;
Bos, J. D. .
BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (04) :808-814
[5]   Psoriatic arthritis: Interrelationships between skin and joint manifestations related to onset, course and distribution [J].
Elkayam, O ;
Ophir, J ;
Yaron, M ;
Caspi, D .
CLINICAL RHEUMATOLOGY, 2000, 19 (04) :301-305
[6]   Infliximab in the treatment of psoriasis in patients previously treated with etanercept [J].
Haitz, Kassie A. ;
Kalb, Robert E. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (01) :120-125
[7]   Etanercept as monotherapy in patients with psoriasis [J].
Leonardi, CL ;
Powers, JL ;
Matheson, RT ;
Goffe, BS ;
Zitnik, R ;
Wang, A ;
Gottlieb, AB ;
Bagel, J ;
Camisa, C ;
Caro, I ;
DiGiovanna, JJ ;
Dunlap, FF ;
Elewski, BE ;
Gribetz, CE ;
Farber, HF ;
Feldman, SR ;
Frankel, EH ;
Gaspari, AA ;
Goodman, JJ ;
Gordon, KB ;
Hampel, FC ;
Herdener, RS ;
Hoffman, MD ;
Humeniuk, JM ;
Johnson, SM ;
Kang, S ;
Kimball, AB ;
Kirsner, RS ;
Korman, NJ ;
Krueger, GG ;
Kuwahara, RT ;
Lebwohl, M ;
Ling, MR ;
Liu, DC ;
Lowe, N ;
McCall, CO ;
Menter, A ;
Miller, BH ;
Moore, JK ;
Nayak, AS ;
Ratner, PH ;
Savin, RC ;
Shupack, JL ;
Smith, SL ;
Stone, SP ;
Swinehart, JM ;
Taborn, J ;
Tschen, EH ;
Weinstein, GD ;
Werth, VP .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21) :2014-2022
[8]   Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study [J].
Paul, CF ;
Ho, VC ;
McGeown, C ;
Christophers, E ;
Schmidtmann, B ;
Guillaume, JC ;
Lamarque, V ;
Dubertret, L .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (02) :211-216
[9]   Psoriasis induced by anti-tumor necrosis factor therapy - A paradoxical adverse reaction [J].
Sfikakis, PP ;
Iliopoulos, A ;
Elezoglou, A ;
Kittas, C ;
Stratigos, A .
ARTHRITIS AND RHEUMATISM, 2005, 52 (08) :2513-2518
[10]  
STROBER B, 2006, ANN M AM AC DERM MAR
1